BioAlert

BioAlert

Continuous monitoring technology for Legionella pneumophila bacteria.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor investor investor investor

€0.0

round
*

N/A

Support Program
Total Funding000k
More about BioAlert
Edit

BioAlert specializes in the development and deployment of automated, on-site Legionella monitoring systems designed for continuous surveillance of water quality in cooling towers and other water systems. Their technology eliminates the need for manual sampling by integrating directly into the cooling system infrastructure, where it performs all tests and sampling automatically. Results are delivered in less than four hours, enabling daily analysis and rapid response to any detected Legionella presence. The system is complemented by a remote-controlled digital platform, allowing facility managers and operators to activate water analyses and monitor test results from any location, thus ensuring ongoing compliance and safety without the need for on-site human intervention. By leveraging IoT and sensor technologies, BioAlert addresses critical health and regulatory concerns associated with Legionella outbreaks, providing a robust solution for organizations tasked with maintaining water safety standards. Their offering is particularly relevant for industries where waterborne pathogens pose operational and health risks, such as building management, healthcare, and industrial operations. Through its innovative approach, BioAlert supports public health goals and regulatory compliance, contributing to safer environments and more efficient facility management

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads